Phenotypic Switching in Cryptococcus neoformans Contributes to Virulence by Changing the Immunological Host Response

ABSTRACT Cryptococcus neoformans is an encapsulated opportunistic organism that can undergo phenotypic switching. In this process, the parent smooth colony (SM) switches to a more virulent mucoid colony (MC) variant. The host responses mounted against the SM and MC variants differ, and lower tissue interleukin 10 (IL-10) levels are consistently observed in lungs of MC-infected C57BL/6 and BALB/c mice. This suggested different roles of this cytokine in SM and MC infections. The objective of this study was to compare survival rates and characterize the host responses of SM- and MC-infected IL-10-depleted (IL-10−/−) mice, which exhibit a Th1-polarized immune response and are considered resistant hosts. As expected, SM-infected IL-10−/− mice survived longer than wild-type mice, whereas MC-infected IL-10−/− mice did not exhibit a survival benefit. Consistent with this observation, we demonstrated marked differences in the inflammatory responses of SM- and MC-infected IL-10−/− and wild-type mice. This included a more Th1-polarized inflammatory response with enhanced recruitment of macrophages and natural killer and CD8 cells in MC- than in SM-infected IL-10−/− and wild-type mice. In contrast, both SM-infected IL-10−/− and wild-type mice exhibited higher recruitment of CD4 cells, consistent with enhanced survival and differences in recruitment and Th1/Th2 polarization. Lung tissue levels of IL-21, IL-6, IL-4, transforming growth factor beta, IL-12, and gamma interferon were higher in MC-infected IL-10−/− and wild-type mice than in SM-infected mice, whereas tumor necrosis factor alpha levels were higher in SM-infected IL-10−/− mice. In conclusion, the MC variant elicits an excessive inflammatory response in a Th1-polarized host environment, and therefore, the outcome is negatively affected by the absence of IL-10.

[1]  Jianfei Yang,et al.  Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells , 2008, European journal of immunology.

[2]  Gesine Hansen,et al.  IL-13 Induces Disease-Promoting Type 2 Cytokines, Alternatively Activated Macrophages and Allergic Inflammation during Pulmonary Infection of Mice with Cryptococcus neoformans1 , 2007, The Journal of Immunology.

[3]  A. Casadevall,et al.  Capsule Structural Heterogeneity and Antigenic Variation in Cryptococcus neoformans , 2007, Eukaryotic Cell.

[4]  Terry B. Strom,et al.  IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells , 2007, Nature.

[5]  A. Casadevall,et al.  The Relative Susceptibility of Mouse Strains to Pulmonary Cryptococcus neoformans Infection Is Associated with Pleiotropic Differences in the Immune Response , 2007, Infection and Immunity.

[6]  T. Harrison,et al.  Immune dysfunction in HIV-seronegative, Cryptococcus gattii meningitis. , 2007, The Journal of infection.

[7]  D. Raoult,et al.  The two faces of interleukin 10 in human infectious diseases. , 2006, The Lancet. Infectious diseases.

[8]  G. Klintmalm,et al.  Systemic and cerebrospinal fluid T-helper cytokine responses in organ transplant recipients with Cryptococcus neoformans infection. , 2006, Transplant immunology.

[9]  F. Bistoni,et al.  Glucuronoxylomannan exhibits potent immunosuppressive properties. , 2006, FEMS yeast research.

[10]  V. Kuchroo,et al.  Tim-2 regulates T helper type 2 responses and autoimmunity , 2005, The Journal of experimental medicine.

[11]  F. Dromer,et al.  Evidence for human immunodeficiency virus and Cryptococcus neoformans interactions in the pro-inflammatory and anti-inflammatory responses in blood during AIDS-associated cryptococcosis. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  J. Erb-Downward,et al.  Distinct Roles for IL-4 and IL-10 in Regulating T2 Immunity during Allergic Bronchopulmonary Mycosis1 , 2005, The Journal of Immunology.

[13]  A. Casadevall,et al.  Effects of Antifungal Interventions on the Outcome of Experimental Infections with Phenotypic Switch Variants of Cryptococcus neoformans , 2005, Antimicrobial Agents and Chemotherapy.

[14]  D. Gordon,et al.  Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  C. Baecher-Allan,et al.  T Cell Ig- and Mucin-Domain-Containing Molecule-3 (TIM-3) and TIM-1 Molecules Are Differentially Expressed on Human Th1 and Th2 Cells and in Cerebrospinal Fluid-Derived Mononuclear Cells in Multiple Sclerosis1 , 2004, The Journal of Immunology.

[16]  F. Dromer,et al.  Cryptococcus neoformans Capsule Structure Evolution In Vitro and during Murine Infection , 2004, Infection and Immunity.

[17]  A. Casadevall,et al.  The damage-response framework of microbial pathogenesis , 2003, Nature Reviews Microbiology.

[18]  A. Casadevall,et al.  Phenotypic switching of Cryptococcus neoformans can influence the outcome of the human immune response , 2003, Cellular microbiology.

[19]  G. Freeman,et al.  The TIM gene family: emerging roles in immunity and disease , 2003, Nature Reviews Immunology.

[20]  G. Huffnagle,et al.  Effects of Tumor Necrosis Factor Alpha on Dendritic Cell Accumulation in Lymph Nodes Draining the Immunization Site and the Impact on the Anticryptococcal Cell-Mediated Immune Response , 2003, Infection and Immunity.

[21]  M. Dorf,et al.  Differential Roles of CC Chemokine Ligand 2/Monocyte Chemotactic Protein-1 and CCR2 in the Development of T1 Immunity1 , 2002, The Journal of Immunology.

[22]  A. Casadevall,et al.  Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. , 2001, The Journal of clinical investigation.

[23]  A. Casadevall,et al.  Both Th1 and Th2 Cytokines Affect the Ability of Monoclonal Antibodies To Protect Mice against Cryptococcus neoformans , 2001, Infection and Immunity.

[24]  G. Cardinali,et al.  Evidence of Microevolution in a Clinical Case of Recurrent Cryptococcus neoformans Meningoencephalitis , 2001, European Journal of Clinical Microbiology and Infectious Diseases.

[25]  A. Casadevall,et al.  Host-pathogen interactions: the attributes of virulence. , 2001, The Journal of infectious diseases.

[26]  M. Olszewski,et al.  The Role of Macrophage Inflammatory Protein-1α/CCL3 in Regulation of T Cell-Mediated Immunity to Cryptococcus neoformans Infection1 , 2000, The Journal of Immunology.

[27]  C. Mody,et al.  Phagocytosis and Protein Processing Are Required for Presentation of Cryptococcus neoformans Mitogen to T Lymphocytes , 2000, Infection and Immunity.

[28]  A. Casadevall,et al.  Cryptococcus neoformans Is a Facultative Intracellular Pathogen in Murine Pulmonary Infection , 2000, Infection and Immunity.

[29]  W. Kuziel,et al.  CCR2 Expression Determines T1 Versus T2 Polarization During Pulmonary Cryptococcus neoformans Infection1 , 2000, The Journal of Immunology.

[30]  T. Harrison,et al.  Effect of interleukin (IL)-15 priming on IL-12 and interferon-gamma production by pathogen-stimulated peripheral blood mononuclear cells from human immunodeficiency virus-seropositive and -seronegative donors. , 2000, The Journal of infectious diseases.

[31]  T. Kozel,et al.  HIV type 1 envelope glycoprotein gp120 induces development of a T helper type 2 response to Cryptococcus neoformans. , 1999, AIDS.

[32]  A. Casadevall,et al.  Phenotypic Switching in Cryptococcus neoformansResults in Changes in Cellular Morphology and Glucuronoxylomannan Structure , 1999, Infection and Immunity.

[33]  J. Cavaillon,et al.  Enhanced Sensitivity of Tumor Necrosis Factor/Lymphotoxin-α—Deficient Mice to Cryptococcus neoformans Infection despite Increased Levels of Nitrite/Nitrate, Interferon-γ, and Interleukin-12 , 1999 .

[34]  M. Kurimoto,et al.  Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines. , 1999, Cellular immunology.

[35]  C. Mody,et al.  The Capsule of Cryptococcus neoformans Reduces T-Lymphocyte Proliferation by Reducing Phagocytosis, Which Can Be Restored with Anticapsular Antibody , 1999, Infection and Immunity.

[36]  A. Adesina,et al.  Differential Regulation of Immune Responses by Highly and Weakly Virulent Cryptococcus neoformansIsolates , 1999, Infection and Immunity.

[37]  H. Okamura,et al.  Combined effects of IL‐12 and IL‐18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans , 1999, European journal of immunology.

[38]  A. Casadevall,et al.  Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  A. Casadevall,et al.  Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. , 1998, The Journal of infectious diseases.

[40]  K. Decken,et al.  Interleukin-12 Is Essential for a Protective Th1 Response in Mice Infected with Cryptococcus neoformans , 1998, Infection and Immunity.

[41]  A. Casadevall,et al.  Organ-Dependent Variation of Capsule Thickness inCryptococcus neoformans during Experimental Murine Infection , 1998, Infection and Immunity.

[42]  G. Huffnagle,et al.  Cells and cytokines in pulmonary cryptococcosis. , 1998, Research in immunology.

[43]  J. Bonnefoy,et al.  IgE versus IgG4 production can be differentially regulated by IL-10. , 1998, Journal of immunology.

[44]  G. Huffnagle,et al.  IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). , 1998, Journal of immunology.

[45]  A. Casadevall,et al.  Microevolution of a Standard Strain ofCryptococcus neoformans Resulting in Differences in Virulence and Other Phenotypes , 1998, Infection and Immunity.

[46]  M. Burdick,et al.  Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. , 1997, Journal of immunology.

[47]  K. Kawakami,et al.  Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12 , 1997, Infection and immunity.

[48]  M. Burdick,et al.  Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. , 1996, Journal of immunology.

[49]  A. Casadevall,et al.  Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. , 1996, Human pathology.

[50]  F. Dromer,et al.  Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  G. Huffnagle,et al.  Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. , 1995, American journal of respiratory cell and molecular biology.

[52]  J. Curtis,et al.  Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. , 1995, Journal of immunology.

[53]  B. Wallaert,et al.  Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis. , 1995, The European respiratory journal.

[54]  A. Casadevall,et al.  Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis , 1995, Infection and immunity.

[55]  K. Buchanan,et al.  Regulation of cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response , 1994, Infection and immunity.

[56]  G. Huffnagle,et al.  The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection , 1994, Journal of leukocyte biology.

[57]  J. Murphy Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response , 1993, Infection and immunity.

[58]  K. Buchanan,et al.  Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response , 1993, Infection and immunity.

[59]  C. Mody,et al.  Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans , 1993, Infection and immunity.

[60]  A. Luca,et al.  IL-17 and Therapeutic Kynurenines in Pathogenic Inflammation to Fungi , 2008 .

[61]  F. Bistoni,et al.  Interleukin-12 counterbalances the deleterious effect of human immunodeficiency virus type 1 envelope glycoprotein gp120 on the immune response to Cryptococcus neoformans. , 2001, The Journal of infectious diseases.

[62]  H. Okamura,et al.  Role of TNF-alpha in the induction of fungicidal activity of mouse peritoneal exudate cells against Cryptococcus neoformans by IL-12 and IL-18. , 1999, Cellular immunology.

[63]  J. Cavaillon,et al.  Enhanced sensitivity of tumor necrosis factor/lymphotoxin-alpha-deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite/nitrate, interferon-gamma, and interleukin-12. , 1999, The Journal of infectious diseases.

[64]  Jay K Kolls,et al.  The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation , 2022 .